File(s) under embargo

Reason: 12 month publisher embargo

1

day(s)

until file(s) become available

The views of ethnic minority and vulnerable communities towards participation in COVID-19 vaccine trials.

journal contribution
posted on 26.11.2020, 10:12 by Winifred Ekezie, Barbara M Czyznikowska, Sundeep Rohit, Julian Harrison, Nasima Miah, Pamela Campbell-Morris, Kamlesh Khunti
The COVID-19 pandemic has disproportionately affected Black, Asian and minority ethnic populations and vulnerable groups.1 Ethnic minority communities have 10–50% higher mortality risk compared with those of white ethnicity in the UK and USA.2,3 Those with mental health conditions, homeless people and vulnerable migrants are also at high risk.4,5 If successful, vaccination will provide protection and management of COVID-19, and to ensure optimal uptake and efficacy of vaccination programmes, the involvement of high-risk groups in vaccine trials is crucial. Ethnic minority individuals are, however, generally underrepresented in medical research, and researchers are actively seeking approaches to include more ethnic minorities in COVID-19 vaccine trials.6 There is, therefore, a pressing need to explore perceptions towards participation in vaccine trials amongst ethnic minority and vulnerable communities towards achieving higher recruitment rates.

Funding

NIHR ARC project

History

Citation

Journal of Public Health, fdaa196, https://doi.org/10.1093/pubmed/fdaa196

Author affiliation

Diabetes Research Centre, College of Life Sciences

Version

AM (Accepted Manuscript)

Published in

Journal of public health

Pagination

fdaa196

Publisher

Oxford University Press (OUP)

issn

1741-3842

eissn

1741-3850

Acceptance date

07/10/2020

Copyright date

2020

Available date

30/10/2021

Spatial coverage

England

Language

eng